From the outside looking in.

Abstract

Public health practitioners are often suspicious of colleagues who work with the pharmaceutical industry. But, by analogy with the legal system, public good flows from allowing commercial interests to present their case as strongly as possible within rules set by the government or National Health Service. In court, both parties work within an agreed framework, but each party presents only one side of the argument. Arguing the commercial case balances the drive for innovation against the inertia of the NHS.